Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals, Inc.
NASDAQ:AMPHHealthcare · Drug Manufacturers - Specialty & Generic
+2.93%$27.72
AH$27.72+0.00%vs close
Mkt Cap$1.18B
Float29.13M
O/S42.54M
Vol
$ Vol
RVOL
Inst Own66.6%
SI14.9%
Earnings
Dilution
Financials Summary
Revenue$719.89M
Net Income$98.09M
Total Assets$1.63B
Free Cash Flow$121.23M
Debt & Equity
Debt 45%
Equity 55%
Total Debt$656M
Total Equity$788.8M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in AMPH's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.63B
Liabilities$840.49M
Accounts Receivable$143.56M
Accounts Payable$32.59M
Inventory$176.89M
PP&E (Net)$353.72M
Goodwill$3.4M
Intangible Assets$562.56M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $719.89M | $731.97M | $644.39M | $498.99M | $437.77M | $349.85M | $322.36M | $294.67M | $240.18M | $255.16M | $251.52M | $210.46M | $229.68M | $204.32M | $118.36M |
| YoY Growth | -1.7% | 13.6% | 29.1% | 14.0% | 25.1% | 8.5% | 9.4% | 22.7% | -5.9% | 1.4% | 19.5% | -8.4% | 12.4% | 72.6% | - |
| Cost of Revenue | $363.83M | $358.11M | $293.27M | $250.13M | $238.03M | $206.51M | $190.43M | $187.68M | $149.38M | $150.98M | $174.17M | $159.21M | $142.72M | $114.02M | $90.25M |
| Gross Profit | $356.06M | $373.86M | $351.12M | $248.86M | $199.74M | $143.34M | $131.92M | $106.98M | $90.8M | $104.19M | $77.35M | $51.26M | $86.96M | $90.3M | $28.1M |
| Gross Margin | 49.5% | 51.1% | 54.5% | 49.9% | 45.6% | 41.0% | 40.9% | 36.3% | 37.8% | 40.8% | 30.8% | 24.4% | 37.9% | 44.2% | 23.7% |
| Research and Development | $85.84M | $73.91M | $73.74M | $74.77M | $60.93M | $67.23M | $68.85M | $57.56M | $43.41M | $41.2M | $37.06M | $28.43M | $33.02M | $31.16M | $31.05M |
| Selling, General, and Administrative | $129.81M | $94.52M | $80.39M | $66.59M | $68.92M | $65.16M | $63.11M | $58.04M | $50.92M | $47.3M | $46.97M | $40.37M | $36.32M | $31.65M | $30.53M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$746K | $0 | -$165K | $508K | $0 | $0 |
| Total Operating Expenses | $215.65M | $168.44M | $154.13M | $141.36M | $129.85M | $132.39M | $131.96M | $115.61M | $94.33M | $88.5M | $84.04M | $68.8M | $69.34M | $62.81M | $61.58M |
| Operating Income (EBIT) | $140.4M | $205.42M | $196.99M | $107.5M | $69.89M | $10.95M | -$39K | -$8.62M | -$895K | $15.69M | -$6.9M | -$17.98M | $17.49M | $25.4M | -$33.55M |
| Operating Margin | 19.5% | 28.1% | 30.6% | 21.5% | 16.0% | 3.1% | -0.0% | -2.9% | -0.4% | 6.1% | -2.7% | -8.5% | 7.6% | 12.4% | -28.3% |
| Interest Expense | $25.48M | $30.34M | $27.16M | $1.85M | $885K | $374K | $119K | $243K | $826K | $1.02M | $987K | $609K | $958K | $784K | $584K |
| Interest Income | $8.68M | $10.61M | $5.46M | $1.32M | $601K | $642K | $997K | $456K | $425K | $270K | $315K | $243K | $187K | $242K | $401K |
| Other Income (Expense) | -$16.78M | -$16.23M | -$27.61M | $7.37M | $14.04M | -$6.32M | $60.27M | -$1.3M | $2.52M | -$746K | -$3.47M | -$165K | -$263K | -$1.61M | $1.66M |
| Income Before Tax (EBT) | $123.62M | $189.19M | $169.38M | $114.86M | $83.93M | $4.64M | $60.23M | -$9.93M | $1.62M | $14.95M | -$10.36M | -$18.15M | $17.23M | $25.88M | -$31.89M |
| Income Tax Expense | $25.53M | $29.67M | $31.83M | $23.48M | $20.63M | $3.54M | $13.72M | -$3.27M | -$2.88M | $4.41M | -$7.58M | -$7.45M | $5.37M | $7.78M | -$39.64M |
| Net Income | $98.09M | $159.52M | $137.54M | $91.39M | $62.12M | $1.4M | $48.94M | -$5.74M | $4.51M | $10.53M | -$2.79M | -$10.7M | $11.86M | $18.09M | $7.75M |
| Net Income Margin | 13.6% | 21.8% | 21.3% | 18.3% | 14.2% | 0.4% | 15.2% | -1.9% | 1.9% | 4.1% | -1.1% | -5.1% | 5.2% | 8.9% | 6.5% |
| Supplementary Data | |||||||||||||||
| EPS | 2.10 | 3.29 | 2.85 | 1.88 | 1.30 | 0.03 | 1.04 | -0.12 | 0.10 | 0.23 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| Diluted EPS | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 | 0.03 | 0.98 | -0.12 | 0.09 | 0.22 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| Weighted Average OS | 46.74M | 48.43M | 48.27M | 48.55M | 47.78M | 47.04M | 46.98M | 46.40M | 46.11M | 45.38M | 44.96M | 41.96M | 8.00M | 8.00M | 8.00M |
| EBITDA | $212.31M | $277.31M | $240.29M | $146.16M | $110.49M | $30.19M | $81.47M | $6.83M | $17.89M | $30.53M | $3.88M | -$3.09M | $30.69M | $38.16M | -$20.15M |
| EBITDA Margin | 29.5% | 37.9% | 37.3% | 29.3% | 25.2% | 8.6% | 25.3% | 2.3% | 7.4% | 12.0% | 1.5% | -1.5% | 13.4% | 18.7% | -17.0% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $170.18M | $151.61M | $144.3M | $156.1M | $126.35M | $92.64M | $75.55M | $86.34M | $65.59M | $72.35M | $66.07M | $67.83M | $53.59M | $50.21M |
| Short-Term Investments | $112.64M | $70.04M | $112.51M | $19.66M | $10.32M | $12.98M | $13.96M | $2.83M | $2.63M | $527K | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $282.81M | $221.65M | $256.81M | $175.76M | $136.67M | $105.62M | $89.52M | $89.17M | $68.23M | $72.88M | $66.07M | $67.83M | $53.59M | $50.21M |
| Accounts Receivable | $143.56M | $138.04M | $115.47M | $88.8M | $78.8M | $66M | $45.38M | $52.16M | $36M | $26.78M | $33.23M | $22.85M | $24.59M | $38.27M |
| Inventory | $176.89M | $153.74M | $105.83M | $103.58M | $92.81M | $96.83M | $110.5M | $69.32M | $63.61M | $79.75M | $70.67M | $82.33M | $69.92M | $51.38M |
| Other Current Assets | $32.75M | $20.65M | $11.49M | $2.61M | $2.56M | $4.45M | $9.85M | $4.2M | $10.19M | $1.41M | $1.52M | $21.3M | $19.85M | $22.19M |
| Total Current Assets | $636.02M | $534.07M | $489.6M | $378.32M | $318.12M | $279.68M | $255.24M | $220.34M | $187.78M | $184.1M | $175.93M | $198M | $172.97M | $165.69M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $353.72M | $344.63M | $315.64M | $264.57M | $271.49M | $280.71M | $253.55M | $210.42M | $185.34M | $152.94M | $142.16M | $138.29M | $116.62M | $107.37M |
| Goodwill | $3.4M | $3.05M | $3.22M | $3.13M | $3.31M | $3.94M | $3.63M | $3.95M | $4.46M | $3.98M | $3.73M | $4.47M | $280K | $280K |
| Intangible Assets | $562.56M | $587.61M | $610.08M | $34.17M | $35.56M | $36.67M | $37.52M | $38.32M | $40.68M | $46.33M | $36.17M | $38.1M | $39.88M | $42.07M |
| Long-Term Investments | $0 | $11M | $15.21M | $2.41M | $3.98M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $42.46M | $71.12M | $53.25M | $38.53M | $22.4M | $24.98M | $25.87M | $30.62M | $27.75M | $31M | $27.44M | $6.93M | $6.12M | $27K |
| Other Long-Term Assets | $31.14M | $25.99M | $25.91M | $20.86M | $16.66M | $5.25M | $11.16M | $9.92M | $8.66M | $9.39M | $4.7M | $3.59M | $2.88M | $2.04M |
| Total Long-Term Assets | $993.28M | $1.04B | $1.02B | $363.67M | $353.41M | $351.55M | $331.73M | $293.22M | $266.89M | $243.64M | $214.2M | $191.37M | $165.78M | $151.79M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.63B | $1.58B | $1.51B | $741.99M | $671.53M | $631.24M | $586.97M | $513.56M | $454.67M | $427.74M | $390.14M | $389.37M | $338.75M | $317.48M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $32.59M | $30.51M | $25.44M | $20.5M | $22.21M | $24.36M | $25.06M | $31.32M | $16.63M | $19.93M | $13.87M | $10.16M | $20.38M | $17.66M |
| Short-Term Debt | $1.64M | $234K | $436K | $3.05M | $2.2M | $12.26M | $10.92M | $18.23M | $6.31M | $5.37M | $10.93M | $7.59M | $22.1M | $22.05M |
| Current Income Tax Payable | $17.17M | $9.66M | $1.61M | $4.57M | $9.08M | $1.08M | $2.04M | $1.19M | $3.33M | $7.71M | $3.08M | $3.12M | $2.85M | $3.03M |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$56.09M | $0 | $97K | $643K | $14.01M | $643K | $642K |
| Other Current Liabilities | $0 | $0 | $0 | $17.55M | $23.16M | $25.19M | $30.12M | $0 | $7.78M | $7.71M | $0 | $15.06M | $0 | $0 |
| Total Current Liabilities | $158.16M | $173.76M | $225.41M | $94.86M | $103.81M | $112.2M | $90.01M | $106.83M | $67.19M | $60.62M | $59.95M | $62.59M | $65.4M | $60.08M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $608.66M | $601.63M | $589.58M | $72.84M | $74.38M | $33.91M | $38.89M | $31.98M | $40.84M | $32.36M | $30.16M | $36.11M | $10.07M | $15.95M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $97K | $1.34M | $1.98M | $2.63M | $3.33M |
| Long-Term Deferred Tax Liabilities | $5.93M | $6.96M | $6.07M | $7.37M | $7.07M | $5.45M | $867K | $1.45M | $2.24M | $2.3M | $497K | $6.34M | $7.15M | $3.19M |
| Other Long-Term Liabilities | $29.98M | $20.95M | $22.72M | $14.56M | $15.65M | $13.21M | $12.86M | $9.36M | $7.94M | $3.96M | $3.17M | $5.63M | $1.95M | $1.49M |
| Total Long-Term Liabilities | $682.34M | $671.41M | $648.08M | $118.47M | $122.2M | $70.31M | $69.43M | $42.37M | $50.14M | $37.87M | $34.67M | $44.91M | $21.8M | $23.96M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $840.49M | $845.17M | $873.49M | $213.33M | $226.01M | $182.51M | $159.44M | $149.2M | $117.34M | $98.48M | $94.63M | $107.51M | $87.2M | $84.04M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $6K | $6K | $6K | $6K | $6K | $5K | $5K | $5K | $5K | $5K | $5K | $4K | $4K | $4K |
| Retained Earnings | $666.88M | $568.79M | $409.27M | $271.72M | $180.34M | $117.77M | $116.37M | $67.48M | $76.23M | $70.86M | $60.32M | $63.11M | $73.81M | $61.95M |
| Comprehensive Income & Other | -$5.31M | -$9.18M | -$8.48M | -$8.62M | -$6.76M | -$3.72M | -$4.69M | -$4.01M | -$2.1M | -$4.7M | -$2.48M | -$1.65M | $0 | $0 |
| Other Stockholders' Equity | $121.92M | $163.5M | $230.15M | $256.93M | $265.18M | $284.53M | $264.99M | $264.94M | $261.09M | $258.39M | $235.18M | $218.75M | $177.73M | $171.49M |
| Total Equity | $788.8M | $732.3M | $639.42M | $528.66M | $445.52M | $402.31M | $381.37M | $332.44M | $337.33M | $329.25M | $295.51M | $281.86M | $251.54M | $233.44M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $46.42M | $46.16M | $31.92M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.63B | $1.58B | $1.51B | $741.99M | $671.53M | $584.82M | $540.81M | $481.64M | $454.67M | $427.74M | $390.14M | $389.37M | $338.75M | $317.48M |
| Supplementary Data | ||||||||||||||
| Total Debt | $656M | $650.55M | $623.64M | $102.58M | $104.66M | $67.27M | $66.63M | $50.21M | $47.16M | $37.72M | $41.1M | $43.7M | $32.17M | $38M |
| Net Debt | $485.82M | $498.94M | $479.35M | -$53.52M | -$21.69M | -$25.37M | -$8.93M | -$36.12M | -$18.44M | -$34.63M | -$24.98M | -$24.13M | -$21.41M | -$12.21M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | $98.09M | $159.52M | $137.54M | $91.39M | $63.3M | $1.1M | $46.51M | -$6.66M | $4.51M | $10.53M | -$2.79M | -$10.7M | $11.86M | $18.09M | $7.75M |
| Depreciation & Amortization | $63.2M | $57.2M | $41.78M | $28.27M | $25.46M | $25.18M | $21.12M | $16.52M | $15.81M | $14.56M | $13.25M | $14.45M | $13.08M | $11.5M | $11.15M |
| Deferred Income Tax | $27.63M | -$17.87M | -$13.74M | -$15.75M | $4.21M | $1.12M | $7.55M | -$1.88M | $3.93M | -$3.27M | -$7.88M | -$8.24M | $2.08M | $8.28M | -$36.01M |
| Stock-Based Compensation | $27.28M | $24.37M | $20.24M | $17.86M | $18.69M | $20.5M | $17.3M | $16.68M | $17.09M | $15.12M | $12.81M | $9.28M | $7.04M | $7.42M | $8.04M |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | -$6.37M | -$21.67M | -$26.09M | -$10.13M | -$14.92M | -$20.16M | $6.7M | -$16.3M | -$8.1M | $6.38M | -$11.01M | $1.21M | $11.82M | -$16.65M | -$1.17M |
| Inventory | -$21.06M | -$48.8M | -$1.72M | -$11.75M | $1.26M | $15.3M | -$41.1M | -$5.98M | $18.65M | -$9.71M | $9.78M | $6.57M | -$18.54M | -$25.22M | -$1.9M |
| Accounts Payable | -$4.56M | $63.56M | $13.24M | -$736K | $3.02M | $14.96M | -$17.94M | $29.16M | $6.69M | -$823K | -$3.13M | $5.5M | $4.2M | -$8.01M | $20.81M |
| Other Working Capital | -$33.98M | -$7.64M | -$9.64M | -$9.56M | $8.72M | -$972K | $591K | $5.22M | -$16.65M | $4.46M | -$770K | $2.34M | -$720K | $228K | $9.84M |
| Total Working Capital Change | -$65.97M | -$14.55M | -$24.21M | -$32.18M | -$1.92M | $9.13M | -$51.75M | $12.1M | $582K | $297K | -$5.14M | $15.62M | -$3.23M | -$49.65M | $27.58M |
| Other Non-Cash Items | $5.89M | $4.71M | $21.89M | -$412K | -$11.74M | $240K | $1.04M | $1.43M | -$2.71M | $1.31M | $420K | $648K | $217K | $2.71M | $581K |
| Net Cash from Operating | $156.12M | $213.39M | $183.5M | $89.18M | $97.99M | $57.27M | $41.76M | $38.19M | $39.21M | $38.56M | $10.68M | $21.05M | $31.04M | -$1.65M | $19.1M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$34.88M | -$41.04M | -$38.17M | -$24.03M | -$27.46M | -$33.85M | -$41.55M | -$46.81M | -$35.1M | -$21.38M | -$16.05M | -$20.5M | -$18.3M | -$25.25M | -$10.72M |
| Acquisitions | $0 | -$129M | -$506.41M | $421K | $0 | $0 | $0 | $4.64M | $2M | -$12.46M | $51K | -$18.35M | $0 | $0 | $0 |
| Purchases of Investments | -$119.13M | -$76.79M | -$144.56M | -$35.76M | -$17.38M | -$13.56M | -$8.81M | -$308K | -$5.64M | -$3.6M | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $90.29M | $126.02M | $38.62M | $27.97M | $18.77M | $12.41M | $0 | $91K | $3.65M | $3.08M | $0 | $0 | $513K | $810K | $185K |
| Other Investing Activities | -$6.61M | -$4.12M | $1.39M | -$1.37M | -$2.61M | -$1.41M | -$157K | $198K | -$3.66M | -$5.13M | -$878K | -$922K | -$509K | -$677K | -$2K |
| Net Cash from Investing | -$70.33M | -$124.93M | -$649.12M | -$32.78M | -$28.67M | -$36.41M | -$50.53M | -$42.18M | -$38.76M | -$39.5M | -$16.93M | -$39.77M | -$18.3M | -$25.11M | -$10.54M |
| Financing Activities | |||||||||||||||
| Debt Repaid | -$5.99M | -$10.17M | -$526.34M | $1.78M | -$32.1M | $880K | $3.21M | -$2.73M | -$9.27M | $4.45M | $2.21M | -$3.29M | $7.15M | -$23.84M | $5.9M |
| Common Stock Issuance | $2.85M | $0 | $0 | $0 | $0 | $0 | $18.3M | $38.04M | $0 | $0 | $0 | $38.02M | $0 | $0 | $0 |
| Common Stock Repurchases | -$75.59M | -$85.46M | -$58.14M | -$39.91M | -$28.87M | -$24.43M | -$22.29M | -$25.05M | -$30.75M | -$9.91M | -$9.87M | -$734K | -$199K | -$811K | -$1.75M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$687K | -$5.67M | -$14.11M | $15.25M | -$40.24M | $23.06M | $3.42M | $8.95M | $13.76M | $21.5M | $14.31M | $35.17M | -$592K | $213K | -$922K |
| Net Cash from Financing | -$67.42M | -$80.95M | $454.09M | -$26.44M | -$37.02M | -$2.25M | -$3.78M | $25.01M | -$7.72M | $7.14M | $2.24M | $32.12M | -$9.37M | $23.24M | -$8.58M |
| Forex Effect | $210K | -$190K | -$282K | -$220K | -$223K | $352K | -$104K | -$274K | $504K | $81K | $2.25M | $845K | $0 | $0 | $0 |
| Net Change in Cash | $18.57M | $7.31M | -$11.8M | $29.75M | $32.08M | $18.96M | -$12.65M | $20.74M | -$6.76M | $6.28M | -$1.75M | $14.24M | $3.37M | -$3.52M | -$15K |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | $156.12M | $213.39M | $183.5M | $89.18M | $97.99M | $57.27M | $41.76M | $38.19M | $39.21M | $38.56M | $10.68M | $21.05M | $31.04M | -$1.65M | $19.1M |
| Capital Expenditure | -$34.88M | -$41.04M | -$38.17M | -$24.03M | -$27.46M | -$33.85M | -$41.55M | -$46.81M | -$35.1M | -$21.38M | -$16.05M | -$20.5M | -$18.3M | -$25.25M | -$10.72M |
| Free Cash Flow | $121.23M | $172.34M | $145.34M | $65.15M | $70.54M | $23.41M | $207K | -$8.62M | $4.11M | $17.18M | -$5.37M | $553K | $12.74M | -$26.89M | $8.38M |
| Cash at Beginning | $151.84M | $144.53M | $156.33M | $126.59M | $94.51M | $75.55M | $88.2M | $67.46M | $72.35M | $66.07M | $67.83M | $53.59M | $50.21M | $53.74M | $53.75M |
| Cash at End | $170.41M | $151.84M | $144.53M | $156.33M | $126.59M | $94.51M | $75.55M | $88.2M | $65.59M | $72.35M | $66.07M | $67.83M | $53.59M | $50.21M | $53.74M |